Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Ratcliffe Liam Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Ratcliffe Liam (Director) has filed a Form 4 on Disc Medicine, Inc.
Txns: Granted 7,136 options to buy @ $45.69, valued at $326k
01/03/2023 4 Ratcliffe Liam (Director) has filed a Form 4 on Disc Medicine, Inc.
Txns: Granted 7,000 options to buy @ $13.5, valued at $94.5k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Ratcliffe Liam (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.46, valued at $34.6k
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2021 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Sold 1,852 shares @ $90.18, valued at $167k
Sold 1,498 shares @ $89.1588, valued at $133.6k
Sold 5,853 shares @ $88.1189, valued at $515.8k
Sold 3,956 shares @ $87.1143, valued at $344.6k
Sold 199 shares @ $86.5861, valued at $17.2k
Sold 5,582 shares @ $87.7089, valued at $489.6k
Sold 18,007 shares @ $86.3813, valued at $1.6M
Sold 36,210 shares @ $85.9247, valued at $3.1M
Sold 17,449 shares @ $85.9583, valued at $1.5M
Sold 9,660 shares @ $84.3141, valued at $814.5k
Sold 12,760 shares @ $84.0204, valued at $1.1M
11/09/2021 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Sold 6,423 shares @ $91.5, valued at $587.7k
Sold 7,060 shares @ $91.5, valued at $646k
Sold 4,940 shares @ $90.75, valued at $448.3k
Sold 5,221 shares @ $91.59, valued at $478.2k
Sold 795 shares @ $90.29, valued at $71.8k
Sold 484 shares @ $89.65, valued at $43.4k
Sold 4,519 shares @ $94.0775, valued at $425.1k
Sold 1,825 shares @ $93.033, valued at $169.8k
Sold 15,327 shares @ $91.8147, valued at $1.4M
Sold 8,676 shares @ $91.0904, valued at $790.3k
Sold 2,747 shares @ $89.863, valued at $246.9k
08/11/2021 4 Ratcliffe Liam (Director) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $12.5, valued at $250k
06/10/2021 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Granted 7,511 options to buy @ $78.53, valued at $589.8k
05/28/2021 4 Ratcliffe Liam (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 16,918 options to buy @ $13.83, valued at $234k
12/21/2020 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Bought 142,857 shares @ $70, valued at $10M
06/04/2020 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Granted 12,000 options to buy @ $33.57, valued at $402.8k
05/27/2020 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Exercised 6,500 options to buy @ $22.06, valued at $143.4k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2019 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Bought 680,000 shares @ $22, valued at $15M
06/18/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2019 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS, INC.
Txns: Granted 12,923 options to buy @ $22.06, valued at $285.1k
04/03/2019 4 Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.
Txns: Granted 4,829 options to buy @ $4.4, valued at $21.2k
04/02/2019 4 Ratcliffe Liam (Director) has filed a Form 4 on Aptinyx Inc.
Txns: Granted 4,123 options to buy @ $4.05, valued at $16.7k
03/18/2019 4 Ratcliffe Liam (Director) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Exercised 10,000 restricted stock units @ $0
01/04/2019 4 Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.
Txns: Granted 4,860 options to buy @ $4.47, valued at $21.7k
10/03/2018 4 Ratcliffe Liam (Director) has filed a Form 4 on ARVINAS INC.
Txns: Converted 1,108,202 shares @ $0
Converted 174,846 shares @ $0
Bought 625,000 shares @ $16, valued at $10M
Bought 375,000 shares @ $16, valued at $6M
Converted 3,601,657 preferred shares @ $0
Converted 568,252 preferred shares @ $0
10/03/2018 4 Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.
Txns: Granted 2,111 options to buy @ $10.37, valued at $21.9k
09/26/2018 4 Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.
Txns: Granted 1,504 options to buy @ $14.57, valued at $21.9k
08/15/2018 4 Ratcliffe Liam (Director) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Granted 10,000 restricted stock units @ $0
06/26/2018 4 Ratcliffe Liam (10% Owner) has filed a Form 4 on Aptinyx Inc.
Txns: Converted 1,047,450 shares @ $0
Converted 1,197,076 shares @ $0
Converted 552,208 shares @ $0
Converted 243,345 shares @ $0
Bought 125,000 shares @ $16, valued at $2M
Bought 125,000 shares @ $16, valued at $2M
Converted 28,895,188 convertible preferred @ $0
Converted 33,022,786 convertible preferred @ $0
Converted 15,233,315 convertible preferred @ $0
Converted 6,712,986 convertible preferred @ $0
06/20/2018 4 Ratcliffe Liam (Director) has filed a Form 4 on Edge Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $1.1, valued at $22k
05/31/2018 4 Lathi Vijay K (10% Owner) has filed a Form 4 on Iterum Therapeutics plc
Txns: Converted 466,793 shares @ $0
Converted 178,230 shares @ $0
Converted 148,603 shares @ $0
Bought 278,062 shares @ $13, valued at $3.6M
Bought 384,615 shares @ $13, valued at $5M
Converted 466,793 options to buy @ $0
Converted 178,230 options to buy @ $0
Converted 148,603 options to buy @ $0
05/21/2018 4 Ratcliffe Liam (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 12,000 options to buy @ $25.73, valued at $308.8k
04/03/2018 4 Ratcliffe Liam (Director) has filed a Form 4 on Unum Therapeutics Inc.
Txns: Converted 622,772 shares @ $0
Converted 622,773 shares @ $0
Bought 275,000 shares @ $12, valued at $3.3M
Bought 275,000 shares @ $12, valued at $3.3M
Converted 977,835 preferred shares @ $0
Converted 977,836 preferred shares @ $0
10/02/2017 4 Ratcliffe Liam (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Converted 839,110 shares @ $0
Converted 1,118,722 shares @ $0
Converted 279,703 shares @ $0
Converted 1,118,722 shares @ $0
Converted 372,883 shares @ $0
Bought 375,000 shares @ $17, valued at $6.4M
Converted 148,515 preferred shares @ $0
Converted 198,004 preferred shares @ $0
Converted 49,505 preferred shares @ $0
Converted 198,004 preferred shares @ $0
Converted 65,997 preferred shares @ $0
06/21/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
10/25/2016 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on iRhythm Technologies, Inc.
Txns: Converted 1,716,589 shares @ $0
Bought 25,000 shares @ $17, valued at $425k
Converted 610,136 convertible preferred @ $0
Converted 190,154 convertible preferred @ $0
Converted 155,548 convertible preferred @ $0
Converted 72,389 options to buy @ $0.001, valued at $72.4
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy